Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Kawasaki Kisen Kaisha Ltd

Start price
Target price
Perf. (%)
€31.10
23.11.23
-
23.11.24
2.70%
25.11.23

buy
Kawasaki Kisen Kaisha Ltd

Start price
Target price
Perf. (%)
€31.10
23.11.23
-
23.11.24
2.70%
25.11.23

buy
Qualigen Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.72
22.11.22
-
22.11.23
-66.14%
23.11.23

Could be worthwhile Investment >10% per year
buy
HelloFresh SE

Start price
Target price
Perf. (%)
€16.36
17.11.23
€18.00
17.11.24
-8.35%
21.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
HelloFresh SE

Start price
Target price
Perf. (%)
€33.50
13.09.23
€35.00
13.09.24
-51.18%
17.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Sphere 3D Corp.

Start price
Target price
Perf. (%)
€2.03
07.07.23
-
07.07.24
-56.65%
14.11.23

Innovative
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.32
29.10.23
€2.80
30.09.25
-
30.10.23

Could be very worthwhile Investment >20% year
buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.28
01.10.23
€2.00
30.09.25
14.84%
29.10.23

Could be very worthwhile Investment >20% year
buy
Gulf Resources Inc.

Start price
Target price
Perf. (%)
€1.65
28.09.23
-
28.09.24
-7.88%
24.10.23

buy
Bridgeline Digital Inc.

Start price
Target price
Perf. (%)
€1.27
16.12.22
-
16.12.23
-45.29%
24.10.23

buy
Schmitt Industries Inc.

Start price
Target price
Perf. (%)
€1.64
17.10.22
-
17.10.23
-99.97%
17.10.23

Probably not worthwhile Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.47
26.09.23
-
26.09.24
-26.87%
15.10.23

Could be very worthwhile Investment >20% year
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.64
30.09.23
€1.00
30.09.24
-9.76%
14.10.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
buy
Cellectis SA ADR

Start price
Target price
Perf. (%)
€2.32
07.10.22
€5.00
07.10.23
-43.97%
08.10.23

Could be worthwhile Investment >10% per year
buy
Leap Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
03.10.23
-
03.10.24
6.62%
04.10.23

buy
Amoeba S.A.

Start price
Target price
Perf. (%)
€0.86
01.10.22
-
01.10.23
-51.16%
02.10.23

Could be worthwhile Investment >10% per year
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€21.88
27.06.23
€2.00
31.10.27
-26.23%
01.10.23

Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.12
27.09.23
-
27.09.24
-35.70%
30.09.23

Risky Investment
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€5.11
16.09.23
€2.00
16.09.24
-14.09%
30.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Pulse Biosciences Inc

Start price
Target price
Perf. (%)
€4.58
13.04.23
-
13.04.26
-14.85%
26.09.23

Risky Investment
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.97
03.09.23
-
03.09.24
-21.32%
13.09.23

Risky Investment
buy
HelloFresh SE

Start price
Target price
Perf. (%)
€29.30
06.09.23
€30.00
06.09.24
14.33%
13.09.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Cameco Corp.

Start price
Target price
Perf. (%)
€29.73
13.09.22
-
13.09.23
20.64%
13.09.23

buy
Cameco Corp.

Start price
Target price
Perf. (%)
€29.73
13.09.22
-
13.09.23
20.64%
13.09.23

BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€2.40
11.09.23
-
11.09.24
-22.50%
12.09.23

Probably not worthwhile Investment